ANAVEX LIFE SCIENCES CORP.: diluted weighted-average shares
Diluted weighted-average shares for ANAVEX LIFE SCIENCES CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ANAVEX LIFE SCIENCES CORP. financial histories
What this measure means
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-10-01 to 2025-09-30. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-10-01 | 2025-09-30 | 85,289,447 | shares | 2026-08-28 | 10-K/A · 0001731122-26-001164 |
| 2023-10-01 | 2024-09-30 | 83,468,049 | shares | 2026-08-28 | 10-K/A · 0001731122-26-001164 |
| 2022-10-01 | 2023-09-30 | 79,787,596 | shares | 2026-08-28 | 10-K/A · 0001731122-26-001164 |
| 2021-10-01 | 2022-09-30 | 76,909,993 | shares | 2023-11-27 | 10-K · 0001731122-23-002197 |
| 2020-10-01 | 2021-09-30 | 69,802,960 | shares | 2023-11-27 | 10-K · 0001731122-23-002197 |
| 2015-10-01 | 2016-09-30 | 35,153,426 | shares | 2016-12-14 | 10-K · 0001615774-16-008914 |
| 2014-10-01 | 2015-09-30 | 18,584,820 | shares | 2016-12-14 | 10-K · 0001615774-16-008914 |
| 2013-10-01 | 2014-09-30 | 9,804,539 | shares | 2016-12-14 | 10-K · 0001615774-16-008914 |
| 2012-10-01 | 2013-09-30 | 31,908,441 | shares | 2014-12-29 | 10-K · 0001062993-14-007294 |
| 2011-10-01 | 2012-09-30 | 28,168,784 | shares | 2013-12-30 | 10-K · 0001062993-13-006497 |
| 2010-10-01 | 2011-09-30 | 25,169,065 | shares | 2012-12-31 | 10-K · 0001062993-12-005603 |
| 2009-10-01 | 2010-09-30 | 21,440,558 | shares | 2011-12-22 | 10-K · 0001062993-11-005004 |
Related financial histories
- ANAVEX LIFE SCIENCES CORP.: total assets
- ANAVEX LIFE SCIENCES CORP.: total liabilities
- ANAVEX LIFE SCIENCES CORP.: stockholders equity
- ANAVEX LIFE SCIENCES CORP.: cash and cash equivalents
- ANAVEX LIFE SCIENCES CORP.: net income or loss
- ANAVEX LIFE SCIENCES CORP.: operating cash flow
- ANAVEX LIFE SCIENCES CORP.: financing cash flow
- ANAVEX LIFE SCIENCES CORP.: investing cash flow
- ANAVEX LIFE SCIENCES CORP.: retained earnings or deficit
- ANAVEX LIFE SCIENCES CORP.: basic weighted-average shares
- ANAVEX LIFE SCIENCES CORP.: basic earnings per share
- ANAVEX LIFE SCIENCES CORP.: diluted earnings per share
- ANAVEX LIFE SCIENCES CORP.: net property, plant and equipment
- ANAVEX LIFE SCIENCES CORP.: share-based compensation expense
- ANAVEX LIFE SCIENCES CORP.: operating income or loss
- ANAVEX LIFE SCIENCES CORP.: current assets
- ANAVEX LIFE SCIENCES CORP.: interest expense
- ANAVEX LIFE SCIENCES CORP.: current liabilities
- ANAVEX LIFE SCIENCES CORP.: current accounts payable
- ANAVEX LIFE SCIENCES CORP.: operating expenses
- ANAVEX LIFE SCIENCES CORP.: selling, general and administrative expense
- ANAVEX LIFE SCIENCES CORP.: research and development expense
Inspect the source
- Entity
- ANAVEX LIFE SCIENCES CORP. / CIK 0001314052
- Captured
- 2026-09-20T07:51:32.244Z
- SEC response SHA-256
58235b1aa01b2e3fa186f80cce94f8ff6bd171b1d8823aeeecb0ffde54d83b04
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001314052.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))